Citius Pharmaceuticals, Inc. (CTXR)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Sep 30
Key ratios (FY2025)
-58.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $90.0K | $90.0K | $90.0K | $90.0K | $75.0K | $50.0K | — |
| Cost of Revenue | — | — | — | — | — | — | — | $75.0K | $50.0K | $45.0K |
| Operating Income | -$38.53M | -$42.00M | -$36.73M | -$33.32M | -$23.53M | -$17.71M | -$15.60M | -$13.79M | -$9.99M | -$7.45M |
| Net Income | -$39.74M | -$39.43M | -$32.54M | -$33.64M | -$23.05M | -$17.55M | -$15.56M | -$12.54M | -$10.38M | — |
| EPS (Diluted) | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 | — | — | — | — | — |
| Total Assets | $130.94M | $116.65M | $103.61M | $114.00M | $142.43M | $43.77M | $36.75M | $31.05M | $24.42M | $21.95M |
| Total Liabilities | $53.41M | $42.55M | $12.18M | $10.57M | $9.65M | $10.10M | $9.59M | — | — | — |
| Shareholders' Equity | $67.55M | $70.08M | $90.83M | $102.83M | $132.18M | $33.67M | $27.15M | $30.64M | $21.95M | $16.77M |
| Cash & Equivalents | $4.25M | $3.25M | $26.48M | $41.71M | $70.07M | $13.86M | $7.89M | $9.18M | $3.20M | $294.4K |
| Operating Cash Flow | -$26.55M | -$28.20M | -$29.06M | -$28.36M | -$24.25M | -$16.93M | -$12.44M | -$11.32M | -$7.97M | -$5.90M |
| Capital Expenditures | — | — | — | — | $6.9K | $1.8K | — | — | $2.1K | — |
| Shares Outstanding | 18.07M | 7.25M | 6.35M | 146.21M | 145.98M | 55.58M | 28.93M | 16.20M | 8.35M | 4.88M |
| Dividends Per Share | — | — | — | — | — | — | — | — | — | $0.60 |